$1.82 Billion is the total value of Bellevue Group AG's 138 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COO | COOPER COS INC | $8,772,000 | +16.4% | 29,619 | 0.0% | 0.48% | -2.6% | |
| TFX | TELEFLEX INC | $5,967,000 | +16.9% | 19,748 | 0.0% | 0.33% | -2.4% | |
| XRAY | DENTSPLY SIRONA INC | $5,498,000 | +33.3% | 110,878 | 0.0% | 0.30% | +11.8% | |
| HOLX | HOLOGIC INC | $4,356,000 | +17.8% | 90,000 | 0.0% | 0.24% | -1.2% | |
| MASI | MASIMO CORP | $3,150,000 | +28.8% | 22,780 | 0.0% | 0.17% | +7.5% | |
| JNJ | JOHNSON & JOHNSON | $2,796,000 | +8.3% | 20,000 | 0.0% | 0.15% | -9.4% | |
| ANGO | ANGIODYNAMICS INC | $1,731,000 | +13.6% | 75,700 | 0.0% | 0.10% | -5.0% | |
| PODD | INSULET CORP | $1,712,000 | +19.9% | 18,000 | 0.0% | 0.09% | 0.0% | |
| MRK | MERCK & CO INC | $1,248,000 | +8.9% | 15,000 | 0.0% | 0.07% | -8.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bellevue Asset Management AG #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.